Pediatric Injectable Drugs (The Teddy Bear Book)
0
Venduto da Basi6 International, Irving, TX, U.S.A.
Venditore AbeBooks dal 24 giugno 2016
Nuovi - Brossura
Condizione: Nuovo
Spedito in U.S.A.
Quantità: 1 disponibili
Aggiungere al carrelloVenduto da Basi6 International, Irving, TX, U.S.A.
Venditore AbeBooks dal 24 giugno 2016
Condizione: Nuovo
Quantità: 1 disponibili
Aggiungere al carrelloNew. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Codice articolo ABEOCT25-404832
If you work with children, you must have this book.
For more than two decades, Pediatric Injectable Drugs (The Teddy Bear Book), has served an important and continuing need for reliable evidence-based information specific to pediatric injectable drugs.
The tenth edition of this invaluable reference has grown to cover 238 drugs commonly used in the treatment of infants and children, including 20 new to this edition. The Teddy Bear Book covers neonates through adolescents, with age-specific dosing and administration guidelines throughout. With three new editors, who collectively bring 75 years of pediatric pharmacy practice experience to the book, the tenth edition is the most thorough and comprehensive reference yet.
As with previous editions, the structure of each of the drug monographs covers the following areas:
Also included is a comprehensive list of abbreviations and more than 4800 references. This is the only pediatric (neonates through adolescents) parenteral drug reference that covers limited fluid amounts, maximum doses, and limited intravenous sitesissues that pediatric practitioners often face in their patients.
When it comes to pediatric injectable drugs, valid safety and efficacy research can be hard to locate. This indispensable reference changes all that.
Stephanie J. Phelps, PharmD, BCPS, received her baccalaureate pharmacy degree from Samford University and a doctor of pharmacy from The University of Tennessee. She subsequently completed postdoctoral training in pediatrics at LeBonheur Childrens Medical Center and The University of Tennessee. Dr. Phelps is currently a Professor of Clinical Pharmacy and Pediatrics at The University of Tennessee Health Science Center (UTHSC) and Associate Dean of Academic Affairs for the College of Pharmacy. For over a decade, she served as Director, of Experiential Education of the college. She is an elected Fellow of American College of Clinical Pharmacy (ACCP) and the American Pharmacists Association (APhA) and is a Board Certified Pharmacotherapy Specialist.
Dr. Phelps has held elected offices in AACP and ASHP and has served on the Board of Directors of American Society of Parenteral and Enteral Nutrition (ASPEN) and the Pediatric Pharmacy Advocacy Group (PPAG). She is currently chair of the Pharmacy Academy of the National Academies of Practice. She is a past recipient of the APhA-Academy of Student Pharmacists Outstanding Chapter Advisor award, the 2009 Tennessee Society of Hospital Pharmacys Distinguished Service Award and was recently selected by PPAG as the 2011 Helms Award recipient for Excellence in Pediatric Pharmacy Practice. Dr. Phelps has received numerous teaching awards and was the first pharmacy faculty member elected to the UTHSC campus Academy of Distinguished Teachers.
During her career she has participated in the education of five post-doctoral fellows and over 50 pediatric pharmacy residents. She is editor of theThe Teddy Bear Book: Pediatric Injectable Drugs and is editor-in-chief of the Journal of Pediatric Pharmacology and Therapeutics. She has published numerous manuscripts, book chapters, and reviews that focus on pediatric pharmacotherapy.
Tracy M. Hagemann, PharmD, FCCP, FPPAG, received her doctor o pharmacy degree from the University of Missouri-Kansas City School of Pharmacy in 1994. She completed a pharmacy practice residency at the Regional Medical Center in Memphis, Tennessee, followed by a pediatric specialty residency at the University of Oklahoma and Childrens Hospital at OU Medical Center in Oklahoma City. Dr. Hagemann is an Associate Professor at the University of Oklahoma College of Pharmacy and an Adjunct Associate Professor at the College of Medicine, Department of Pediatrics. Her focus of practice and research is in pediatric hematology and oncology
. She is an elected fellow of both the American College of Clinical Pharmacy and the Pediatric Pharmacy Advocacy Group. She is an active member of various national pharmacy organizations and has held elected offices in PPAG, as well as the Oklahoma Society of Health-Systems Pharmacists. Her teaching and research has resulted in the publication of over 40 peer-reviewed journal articles and over 50 scientific abstracts. Dr. Hagemann has published book chapters in pediatric sickle cell disease in addition to her co-editorship of Pediatric Injectable Drugs.
Kelley R. Lee, PharmD, BCPS, received her doctorate of pharmacy degree from The University of Tennessee Health Science Center. She completed a two-year residency in pediatric pharmacotherapy at Le Bonheur Childrens Hospital and The University of Tennessee Health Science Center. After residency training, Dr. Lee served as a Clinical Pharmacy Specialist and then the Clinical Pharmacy Manager at Le Bonheur Childrens Hospital and part-time Professor of Clinical Pharmacy at the University of Tennessee Health Science Center. She has recently shifted focus to infectious diseases and is currently a Clinica
Stephanie J. Phelps, PharmD, BCPS, received her baccalaureate pharmacy degree from Samford University and a doctor of pharmacy from The University of Tennessee. She subsequently completed postdoctoral training in pediatrics at LeBonheur Childrens Medical Center and The University of Tennessee. Dr. Phelps is currently a Professor of Clinical Pharmacy and Pediatrics at The University of Tennessee Health Science Center (UTHSC) and Associate Dean of Academic Affairs for the College of Pharmacy. For over a decade, she served as Director, of Experiential Education of the college. She is an elected Fellow of American College of Clinical Pharmacy (ACCP) and the American Pharmacists Association (APhA) and is a Board Certified Pharmacotherapy Specialist.
Dr. Phelps has held elected offices in AACP and ASHP and has served on the Board of Directors of American Society of Parenteral and Enteral Nutrition (ASPEN) and the Pediatric Pharmacy Advocacy Group (PPAG). She is currently chair of the Pharmacy Academy of the National Academies of Practice. She is a past recipient of the APhA-Academy of Student Pharmacists Outstanding Chapter Advisor award, the 2009 Tennessee Society of Hospital Pharmacys Distinguished Service Award and was recently selected by PPAG as the 2011 Helms Award recipient for Excellence in Pediatric Pharmacy Practice. Dr. Phelps has received numerous teaching awards and was the first pharmacy faculty member elected to the UTHSC campus Academy of Distinguished Teachers.
During her career she has participated in the education of five post-doctoral fellows and over 50 pediatric pharmacy residents. She is editor of theThe Teddy Bear Book: Pediatric Injectable Drugs and is editor-in-chief of the Journal of Pediatric Pharmacology and Therapeutics. She has published numerous manuscripts, book chapters, and reviews that focus on pediatric pharmacotherapy.
Tracy M. Hagemann, PharmD, FCCP, FPPAG, received her doctor o pharmacy degree from the University of Missouri-Kansas City School of Pharmacy in 1994. She completed a pharmacy practice residency at the Regional Medical Center in Memphis, Tennessee, followed by a pediatric specialty residency at the University of Oklahoma and Childrens Hospital at OU Medical Center in Oklahoma City. Dr. Hagemann is an Associate Professor at the University of Oklahoma College of Pharmacy and an Adjunct Associate Professor at the College of Medicine, Department of Pediatrics. Her focus of practice and research is in pediatric hematology and oncology
. She is an elected fellow of both the American College of Clinical Pharmacy and the Pediatric Pharmacy Advocacy Group. She is an active member of various national pharmacy organizations and has held elected offices in PPAG, as well as the Oklahoma Society of Health-Systems Pharmacists. Her teaching and research has resulted in the publication of over 40 peer-reviewed journal articles and over 50 scientific abstracts. Dr. Hagemann has published book chapters in pediatric sickle cell disease in addition to her co-editorship of Pediatric Injectable Drugs.
Kelley R. Lee, PharmD, BCPS, received her doctorate of pharmacy degree from The University of Tennessee Health Science Center. She completed a two-year residency in pediatric pharmacotherapy at Le Bonheur Childrens Hospital and The University of Tennessee Health Science Center. After residency training, Dr. Lee served as a Clinical Pharmacy Specialist and then the Clinical Pharmacy Manager at Le Bonheur Childrens Hospital and part-time Professor of Clinical Pharmacy at the University of Tennessee Health Science Center. She has recently shifted focus to infectious diseases and is currently a Clinical Pharmacy Specialist in Antimicrobial Stewardship at Le Bonheur Childrens Hospital. Her practice and research interests have primarily been the appropriate use of medications in pediatric patients, particularly with the use of antibiotics. She has published numerous manuscripts, abstracts, and letters-to-the-editor on this subject.
A Jill Thompson, PharmD, BCPS, earned her doctor of pharmacy degree from the University of Tennessee Health Science Center in 2001, and completed PGY1 and PGY2 residencies in Pediatric Pharmacy Practice at Le Bonheur Childrens Medical Center in Memphis, Tennessee, from 2001 to 2003. Dr. Thompson is the Coordinator of Pediatric Clinical Pharmacy Services and is a Clinical Specialist in Pediatric Critical Care in the Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina. She also serves as an Adjunct Assistant Professor in the Department of Clinical Pharmacy and Outcomes Sciences at the South Carolina College of Pharmacy, MUSC Campus. Dr. Thompson participates in clinical research regarding pediatric critical care and works closely with the pharmacy residency programs at MUSC. She is recognized as a Board Certified Pharmacotherapy Specialist and is a member of the American College of Clinical Pharmacy, Pediatric Pharmacy Advocacy Group, and the Society of Critical Care Medicine. Prior to becoming a co-editor of Pediatric Injectable Drugs, she served as manuscript editor for theJournal of Pediatric Pharmacology and Therapeutics for seven years and is now a member of the editorial board.
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Visita la pagina della libreria
Professional Book Seller shipping from Multiple Locations Worldwide for fastest delivery possible!
Se sei un consumatore puoi recedere dal contratto in conformità con quanto segue. Per Consumatore si intende qualsiasi persona fisica che agisce per scopi estranei alla propria attività commerciale, imprenditoriale, artigianale o professionale.
Informazioni sul diritto di recesso
Diritto legale di recesso
Hai il diritto di recedere dal presente contratto entro 14 giorni senza fornire alcuna motivazione.
Il periodo di recesso scade dopo 14 giorni dal giorno in cui tu o una terza parte, diversa dal vettore e da te indicata, acquisisce il possesso fisico dell'ultimo bene o dell'ultimo lotto o pezzo.
Per esercitare il diritto di recesso, compila e invia elettronicamente una dichiarazione esplicita sul nostro sito Web, alla voce “I miei acquisti” nella sezione “Mio account”. Ti comunicheremo senza indugio una conferma di ricezione di tale recesso su un supporto durevole (ad es. via e-mail).
Per rispettare il termine di recesso, è sufficiente inviare la comunicazione relativa all'esercizio del diritto di recesso prima della scadenza del periodo di recesso stesso.
Effetti del recesso
In caso di recesso dal presente contratto, ti rimborseremo tutti i pagamenti ricevuti, compresi i costi di spedizione (ad eccezione dei costi supplementari derivanti dalla tua eventuale scelta di un tipo di spedizione diverso dal tipo meno costoso di consegna standard da noi offerto).
Potremo effettuare una detrazione dal rimborso per la perdita di valore dei beni forniti, qualora tale perdita sia il risultato di una manipolazione non necessaria da parte tua.
Eseguiremo il rimborso senza indebito ritardo e non oltre 14 giorni dal giorno in cui saremo informati della tua decisione di recedere dal presente contratto.
Il rimborso sarà effettuato utilizzando lo stesso mezzo di pagamento da te usato per la transazione iniziale, salvo che tu non abbia espressamente concordato altrimenti; in ogni caso, non dovrai sostenere alcun costo quale conseguenza di tale rimborso.
Possiamo trattenere il rimborso finché non avremo ricevuto i beni oppure finché non avrai fornito la prova di averli rispediti, a seconda di quale condizione si verifichi per prima.
Dovrai rispedire i beni o consegnarli a Basi6 International, Irving, Texas, U.S.A., senza indebito ritardo e, in ogni caso, entro 14 giorni dal giorno in cui ci hai comunicato la tua volontà di recedere dal presente contratto. Il termine è rispettato se rispedisci i beni prima della scadenza del periodo di 14 giorni. I costi diretti della restituzione dei beni saranno a tuo carico. Sei responsabile solo della diminuzione del valore dei beni risultante da una manipolazione diversa da quella necessaria per stabilire la natura, le caratteristiche e il funzionamento dei beni stessi.
Eccezioni al diritto di recesso
Il diritto di recesso non si applica a:
All orders shipped via FedEx or DHL and delivered to your doorstep within 3-5 days. We do not ship to P.O.Boxes and a proper street address must be provided to avoid any delays.
| Quantità dell'ordine | Da 5 a 14 giorni lavorativi | Da 3 a 6 giorni lavorativi |
|---|---|---|
| Primo articolo | EUR 0.00 | EUR 0.00 |
I tempi di consegna sono stabiliti dai venditori e variano in base al corriere e al paese. Gli ordini che devono attraversare una dogana possono subire ritardi e spetta agli acquirenti pagare eventuali tariffe o dazi associati. I venditori possono contattarti in merito ad addebiti aggiuntivi dovuti a eventuali maggiorazioni dei costi di spedizione dei tuoi articoli.